Lee Sung 4
4 · CYTOKINETICS INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
Lee Sung
EVP, Chief Financial Officer
Transactions
- Award
Incentive Stock Option (Right to Buy)
2025-03-14+9,016→ 9,016 totalExercise: $44.36From: 2025-04-14Exp: 2035-03-13→ Common Stock (9,016 underlying) - Award
Common Stock
2025-03-14+32,687→ 74,442 total - Award
Non-Qualified Stock Option (Right to Buy)
2025-03-14+41,326→ 41,326 totalExercise: $44.36From: 2025-04-14Exp: 2035-03-13→ Common Stock (41,326 underlying)
Footnotes (3)
- [F1]Comprised of restricted stock units that convert to shares of common stock on a 1:1 basis upon vesting. 40% of the RSUs will vest on the 1-year anniversary of the date of grant; an additional 40% of the RSUs will vest on the 2-year anniversary of the date of grant; and the final 20% of the RSUs will vest on the 3-year anniversary of the date of grant, in each case subject to Mr. Lee's continued employment with the company on the scheduled vesting date.
- [F2]Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Lee's continued employment with the company on the scheduled vesting date.
- [F3]Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Lee's continued employment with the company on the scheduled vesting date.